Cargando…
Maternal and Neonatal Circulating Markers of Metabolic and Cardiovascular Risk in the Metformin in Gestational Diabetes (MiG) Trial: Responses to maternal metformin versus insulin treatment
OBJECTIVE: This study was designed to compare glucose, lipids, and C-reactive protein (CRP) in women with gestational diabetes mellitus treated with metformin or insulin and in cord plasma of their offspring and to examine how these markers relate to infant size at birth. RESEARCH DESIGN AND METHODS...
Autores principales: | Barrett, Helen L., Gatford, Kathryn L., Houda, Candice M., De Blasio, Miles J., McIntyre, H. David, Callaway, Leonie K., Dekker Nitert, Marloes, Coat, Suzette, Owens, Julie A., Hague, William M., Rowan, Janet A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579335/ https://www.ncbi.nlm.nih.gov/pubmed/23048188 http://dx.doi.org/10.2337/dc12-1097 |
Ejemplares similares
-
Determinants of Maternal Triglycerides in Women With Gestational Diabetes Mellitus in the Metformin in Gestational Diabetes (MiG) Study
por: Barrett, Helen L., et al.
Publicado: (2013) -
Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7–9 years of age
por: Rowan, Janet A, et al.
Publicado: (2018) -
Blood pressure measurement at two years in offspring of women randomized to a trial of metformin for GDM: follow up data from the MiG trial
por: Battin, Malcolm R, et al.
Publicado: (2015) -
Contributions of the maternal oral and gut microbiome to placental microbial colonization in overweight and obese pregnant women
por: Gomez-Arango, Luisa F., et al.
Publicado: (2017) -
Glycemia and Its Relationship to Outcomes in the Metformin in Gestational Diabetes Trial
por: Rowan, Janet A., et al.
Publicado: (2010)